1. Home
  2. GRFS vs RYAN Comparison

GRFS vs RYAN Comparison

Compare GRFS & RYAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.93

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Logo Ryan Specialty Holdings Inc.

RYAN

Ryan Specialty Holdings Inc.

HOLD

Current Price

$39.43

Market Cap

6.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
RYAN
Founded
1940
2010
Country
Spain
United States
Employees
23800
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GRFS
RYAN
Price
$8.93
$39.43
Analyst Decision
Hold
Buy
Analyst Count
2
15
Target Price
$10.15
$57.71
AVG Volume (30 Days)
446.1K
2.7M
Earning Date
01-01-0001
05-15-2026
Dividend Yield
1.54%
1.37%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,051,126,000.00
Revenue This Year
$5.47
$19.28
Revenue Next Year
$4.92
$13.30
P/E Ratio
$18.67
$86.72
Revenue Growth
N/A
21.28
52 Week Low
$6.19
$37.29
52 Week High
$11.14
$77.00

Technical Indicators

Market Signals
Indicator
GRFS
RYAN
Relative Strength Index (RSI) 42.21 35.30
Support Level $8.66 $37.29
Resistance Level $9.11 $59.52
Average True Range (ATR) 0.29 2.15
MACD -0.05 -0.23
Stochastic Oscillator 42.28 18.74

Price Performance

Historical Comparison
GRFS
RYAN

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About RYAN Ryan Specialty Holdings Inc.

Ryan Specialty Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Share on Social Networks: